David J. Schlanger - 01 Sep 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Signature
/s/ Mark Livingston, Attorney-in-Fact
Issuer symbol
PGNY
Transactions as of
01 Sep 2022
Net transactions value
-$1,614,316
Form type
4
Filing time
06 Sep 2022, 16:21:55 UTC
Previous filing
12 Aug 2022
Next filing
09 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $37,917 +41,667 +50% $0.9100* 124,215 01 Sep 2022 Direct
transaction PGNY Common Stock Sale $1,625,430 -41,667 -34% $39.01 82,548 01 Sep 2022 Direct F1, F2
transaction PGNY Common Stock Options Exercise $637 +700 +0.85% $0.9100* 83,248 02 Sep 2022 Direct
transaction PGNY Common Stock Sale $27,440 -700 -0.84% $39.20 82,548 02 Sep 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Option (Right to Buy) Options Exercise $0 -41,667 -2.6% $0.000000 1,567,013 01 Sep 2022 Common Stock 41,667 $0.9100 Direct F4
transaction PGNY Option (Right to Buy) Options Exercise $0 -700 -0.04% $0.000000 1,566,313 02 Sep 2022 Common Stock 700 $0.9100 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.85 to $39.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.03 to $39.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F4 These options are fully vested and exercisable.